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Introduction
Acute mesenteric ischemia is an uncommon but
devastating emergency, occurring mostly in elderly
patients and with an overall mortality rate ranging
from 60% to 90%.1–3 Factors associated with this high
mortality include atypical clinical presentations
(subacute nature of symptom progression),4 lack of
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predisposing disease, and diagnostic difficulties leading
to delayed surgical intervention.5,6 A high index of
suspicion for the disease and an aggressive diagnostic
approach are essential for early identification and
surgical intervention to increase survival7,8 and reduce
the risk of malpractice claims.9 The primary role of
emergency physicians in evaluating acute abdominal
pain is to distinguish benign abdominal disorders from
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ischemia-related syndromes.10 Further, the clinical
presentations associated with a high risk of mortality in
patients with acute mesenteric ischemia should be
identified to provide appropriate risk stratification in
the emergency department (ED). The purpose of this
study was to demonstrate such initial clinical
presentations and investigate prognostic risk factors in
ED patients with acute mesenteric ischemia.
Methods
Study population
Cases of acute mesenteric ischemia were first identified
from a computer search for hospital discharge codes
(International Classification of Diseases) of 557.0 and
557.9. The diagnosis of mesenteric infarction was
made by surgical intervention and later confirmed by
histologic results. Only patients admitted through the
ED and treated on medical or surgical wards were
enrolled. Eight patients with mesenteric ischemia
secondary to mechanical obstruction, adhesions, or
volvulus were excluded, as were patients less than 14
years of age. Data about demographics, initial clinical
presentations, predisposing diseases, previous
medications, laboratory tests, and the common findings
on computed tomography (CT) scans11 with contrast
were evaluated in 124 patients classified into 2 groups
according to outcome: survival or death.
Statistical analysis
Categoric variables were compared between groups
using the Chi-squared or Fisher’s exact test for qualita-
tive data. The Mann-Whitney non-parametric U-test or
t test was used to analyze quantitative data. Multiple
logistic regression analyses were applied to determine
the independent variables predictive of patient outcomes.
The Hosmer-Lemeshow goodness-of-fit test and the
likelihood ratio test for model selection were performed.
When applicable, tests were 2-tailed. A p value of less
than 0.05 was considered statistically significant.
Results
From September 1990 to September 2000, 124
patients (104 males and 20 females) with acute
mesenteric ischemia, identified by surgical intervention
and pathologic confirmation, were enrolled. The initial
ED and admission medical records of all patients were
reviewed.
Mean patient age was 71.1 years (range, 25–100
years) (Figure 1), with 99 patients (79.8%) older than
65 years. Table 1 lists demographic data, major underlying
disorders, medications, and causes for all patients with
acute mesenteric ischemia. Patients who died were
significantly older than those who survived (74.3 vs
67.9 years; p < 0.01). Hypertension (29.8% of patients),
arrhythmias (27.4%), and cerebral vascular diseases
(19.4%) were the most common underlying conditions
(Table 1). No statistically significant differences were
evident between survivors and non-survivors regarding
major predisposing disorders, medications used, and
causes of acute mesenteric ischemia.
The mean duration of signs and symptoms before
ED visit was shorter (but not significantly) in survivors
than non-survivors (54.0 ± 102.2 hr vs 62.6 ± 82.4
hr); and corresponding mean durations of operation
after ED visit were also not significantly different
(36.0 ± 98.0 hr vs 53.8 ± 100.9 hr) (Table 2).
Significantly more survivors than non-survivors had a
history of abdominal pain at clinical presentation
(91.9% vs 74.2%; p = 0.02), and systolic blood pressure
was significantly greater in survivors than non-survivors
(129.5 vs 114.8 mmHg; p < 0.01). In laboratory tests,
leukocytosis (white blood cell count > 10,800/mm3)
was noted in 80 patients (64.5%), and band-form
shifting in 64 (51.6%). Septic syndrome and metabolic
acidosis were noted significantly less frequently, and
significantly lower values were documented for
bandemia, blood urea nitrogen (BUN), creatinine,
aspartate aminotransferase (AST), alanine amino-
transferase, and amylase, in survivors than non-
survivors (p ) 0.03) (Table 2).
In radiologic studies, plain abdominal films revealed
abnormal findings in 16 of 74 patients (21.6%). These
abnormal findings included bowel-wall thickening
(n = 12), intestinal loop or ileus (7), and pneumatosis
intestinalis (2). Fifty-six patients (45.2%) underwent
Figure 1. Age distribution in 124 patients with acute mesenteric
infarction (mean age, 71.1 ± 12.0 years).
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Table 1. Comparison of demographic characteristics, major underlying disorders, and causes of acute mesenteric ischemia
between groups
Number (%) of patients
p
Survivors (n = 62) Non-survivors (n = 62)
Age, yr* 67.9 ± 13.7 74.3 ± 9.1 < 0.01
Male/female 54/8 50/12 NS
Underlying disease
Hypertension 20 (32.3) 17 (27.4) NS
Arrhythmias 16 (25.8) 18 (29.0) NS
Cerebral vascular diseases 11 (17.7) 13 (21.0) NS
Diabetes mellitus 9 (14.5) 10 (16.1) NS
Coronary artery disease 12 (19.4) 4 (6.5) 0.06
Renal disease† 4 (6.5) 12 (19.4) 0.06
Congestive heart failure 5 (8.1) 4 (6.5) NS
Previous myocardial infarction 4 (6.5) 4 (6.5) NS
Malignancy 4 (6.5) 3 (4.8) NS
Hematologic disease 2 (3.2) 1 (1.6) NS
Valvular heart disease 5 (8.1) 1 (1.6) NS
Systemic lupus erythematosus 1 (1.6) 0 (0) NS
Medications
Antiplatelet 10 (16.1) 4 (6.5) NS
Anticoagulant 5 (8.1) 0 (0) 0.06
Anti-angina 11 (17.7) 6 (9.7) NS
Causes of acute mesenteric ischemia
Superior mesenteric artery embolus 23 (37.1) 26 (41.9) NS
Non-occlusive mesenteric infarction 17 (27.4) 15 (24.2) NS
Superior mesenteric artery thrombosis 8 (12.9) 8 (12.9) NS
Mesenteric venous thrombosis 6 (9.7) 6 (9.7) NS
Unknown 8 (12.9) 7 (11.3) NS
*Mean ± standard deviation; †chronic renal insufficiency or failure. NS = not significant.
Table 2. Comparison of initial clinical presentations, laboratory results, and hospital stays between groups
Number (%) of patients
p
Survivors (n = 62) Non-survivors (n = 62)
Duration of signs and symptoms before ED visit, hr* 54.0 ± 102.2 62.6 ± 82.4 NS
Duration of operation after ED visit, hr* 36.0 ± 98.0 53.8 ± 100.9 NS
Signs and symptoms
Abdominal pain 57 (91.9) 46 (74.2) 0.02
Vomiting 32 (51.6) 22 (35.5) NS
Abdominal distension 9 (14.5) 15 (24.2) NS
Hypotension 4 (6.5) 11 (17.7) NS
Diarrhea 15 (24.2) 9 (14.5) NS
Bloody stools 8 (12.9) 5 (8.1) NS
Tarry stools 2 (3.2) 4 (6.5) NS
Coffee-ground vomitus 3 (4.8) 4 (6.5) NS
Hematemesis 0 (0) 1 (1.6) NS
Chest pain 0 (0) 1 (1.6) NS
Table 2 is continued on the next page...
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Table 2. Comparison of initial clinical presentations, laboratory results, and hospital stays between groups
Number (%) of patients
p
Survivors (n = 62) Non-survivors (n = 62)
Physical findings
Body temperature, ºC* 36.7 ± 1.0 36.6 ± 1.4 NS
Pulse rate, per min* 94.7 ± 24.4 102.3 ± 27.1 NS
Systolic blood pressure, mmHg* 129.5 ± 35.0 114.8 ± 37.2 < 0.01
Abdominal tenderness 59 (95.2) 53 (85.5) NS
Decreased or absent bowel sounds 37 (59.7) 45 (72.6) NS
Rebounding pain 39 (62.9) 34 (54.8) NS
Muscle guarding 20 (32.3) 24 (38.7) NS
Laboratory results*
WBC, mm3 (n = 124) 12,725.7 ± 4,727.4 15,205.3 ± 8,908.0 NS
Band, % (n = 124) 3.1 ± 9.5 14.9 ± 18.4 < 0.01
Segment, % (n = 124) 78.3 ± 15.7 66.7 ± 21.5 < 0.01
Lymphocyte, % (n = 124) 13.5 ± 10.8 10.3 ± 7.8 NS
Platelet, × 103/mm3 (n = 124) 226.2 ± 110.6 197.8 ± 112.3 NS
Hct, % (n = 124) 39.7 ± 7.8 38.5 ± 8.8 NS
BUN, mg/dL (n = 124) 33.5 ± 35.3 53.8 ± 42.0 < 0.01
Creatinine, mg/dL (n = 124) 2.0 ± 1.8 3.6 ± 4.1 < 0.01
LDH, U/L (n = 93) 323.9 ± 162.0 429.1 ± 520.9 NS
AST, U/L (n = 115) 45.8 ± 46.9 159.8 ± 409.1 < 0.01
ALT, U/L (n = 114) 24.6 ± 17.5 79.9 ± 181.6 0.02
ALP, U/L (n = 110) 82.9 ± 32.8 99.6 ± 62.6 NS
CK, U/L (n = 110) 505.0 ± 1,359.3 570.5 ± 1,046.2 NS
Amylase, U/L (n = 107) 146.1 ± 116.8 434.8 ± 569.0 < 0.01
Phosphate, U/L (n = 18) 3.3 ± 1.9 4.9 ± 13.0 NS
pH (n = 111) 7.42 ± 0.08 7.32 ± 0.16 < 0.01
PO2, mmHg (n = 111) 129.6 ± 108.2 117.2 ± 98.8 NS
PCO2, mmHg (n = 111) 29.9 ± 7.7 29.5 ± 11.8 NS
HCO3, mmol/L (n = 111) 19.9 ± 5.8 15.4 ± 6.7 < 0.01
SaO2, % (n = 111) 96.3 ± 3.5 94.4 ± 5.2 0.04
CRP, mg/dL (n = 26) 7.2 ± 10.4 8.8 ± 11.6 NS
PT, sec (n = 82) 23.0 ± 34.6 18.6 ± 11.9 NS
aPTT, sec (n = 85) 49.8 ± 41.3 46.1 ± 21.8 NS
Sepsis† 19 (30.6) 33 (53.2) 0.02
Sepsis-induced hypotension† 4 (6.5) 13 (21.0) 0.03
Metabolic acidosis‡ 8 (12.9) 30 (48.4) < 0.01
*Mean ± standard deviation; †the definitions of sepsis and sepsis-induced hypotension were adopted from reference 26; ‡metabolic acidosis =
serum pH < 7.36 and HCO3 < 24 mmol/L.
ALP = alkaline phosphatase; ALT = alanine aminotransferase; aPTT = activated partial thromboplastin time; AST = aspartate aminotransferase;
BUN = blood urea nitrogen; CK = creatine phosphokinase; CRP = C-reactive protein; ED = emergency department; HCO3 = bicarbonate; Hct = hematocrit;
LDH = lactate dehydrogenase; NS = not significant; PCO2 = partial pressure of carbon dioxide in arterial blood; PO2 = partial pressure of oxygen
in arterial blood; PT = prothrombin time; SaO2 = arterial oxygen concentration; WBC = white blood cell count.
Table 3. Comparison of common computed tomography findings* of mesenteric ischemia in survivors and non-survivors
Number (%) of patients
p
Survivors (n = 25) Non-survivors (n = 31)
Intestinal bowel-wall thickening with or without wall enhancement 20 (80.0) 16 (51.6) 0.03
Intramural pneumatosis 1 (4.0) 14 (45.2) < 0.01
Mesenteric or portal vein gas 2 (8.0) 7 (22.6) NS
Mesenteric artery or vein thrombosis 8 (32.0) 6 (19.4) NS
*Adapted from reference 11. NS = not significant.
Continued from the previous page...
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CT scan with intravenous contrast before surgical
intervention. Table 3 demonstrates the most common
CT imaging findings, including bowel-wall thickening
(Figure 2) in 36 patients, intramural pneumatosis
(Figure 3) in 15, mesenteric artery or vein thrombosis
(Figure 4) in 14, and mesenteric or portal vein gas
(Figure 5) in 9. CT findings of intramural pneumatosis
indicated a poor prognosis (p < 0.01). Fourteen patients
(11.3%) underwent angiography, which revealed
occlusion of the superior mesenteric artery with an
embolus or thrombus (n = 8), and non-occlusive
mesenteric vessels with hypoperfusion (6).
Figure 2. Computed tomography findings: bowel-wall thickening
in jejunal loops in the left abdomen (arrow).
Figure 3. Computed tomography findings: annular intramural air
(intramural pneumatosis) is demonstrated over multiple small-
bowel loops in the lower abdomen (arrows).
Figure 4. Computed tomography findings: (A) patency (contrast-enhanced, arrow) of the proximal superior mesenteric artery; (B) in-
traluminal filling defect, which was found to be thrombosis during surgery, is noted in the distal superior mesenteric artery (arrow).
Figure 5. Computed tomography findings: (A) massive portal vein air is noted in both portal veins (arrow); (B) air was also demonstrated
in the superior mesenteric vein and mesenteric vein (arrow).
A B
A B
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Table 4 demonstrates that more survivors than
non-survivors underwent bowel resection (87.1% vs
66.1%; p = 0.01). The rate of laparotomy only (i.e.
open and closed, without revascularization) was
significantly lower in survivors than non-survivors
(3.2% vs 29.0%; p < 0.01), because of diffuse bowel
gangrene and the catastrophic clinical condition of
patients in the latter group.
Independent predictors of mortality, based on mul-
tiple logistic backward analyses, were old age (> 65
years; odds ratio, OR, 1.077; 95% confidence interval,
CI, 1.013, 1.146; p = 0.02), bandemia (OR, 3.894;
95% CI, 1.160, 13.074; p = 0.03), elevated AST (OR,
4.532; 95% CI, 1.274, 16.122; p = 0.02) and BUN
(OR, 7.219; 95% CI, 1.166, 44.696; p = 0.03), and
metabolic acidosis (OR, 6.604; 95% CI, 1.804,
24.171; p < 0.01). Among 124 patients studied, 85
(68.5%) satisfied the criteria of old age, bandemia,
elevated AST and BUN, and metabolic acidosis. In 16
of these 85 patients (18.8%) who had concurrent
bandemia and elevated AST and BUN levels, the mor-
tality rate was 93.8%. The sensitivity and specificity
for predicting mortality were 68.9% and 74.2%,
respectively, for bandemia (p < 0.001); 62.1% and
78.9% for elevated AST (p < 0.001); 88.5% and 38.3%
for elevated BUN (p < 0.05); and 53.6% and 85.5% for
metabolic acidosis (p < 0.001). The Hosmer-Lemeshow
statistic was not significant, indicating little departure
from a perfect fit (r2 = 4.5; df = 8; p = 0.809). Area under
the receiver-operating characteristic (ROC) curve for
the model was 0.852 (95% CI, 0.779, 0.925), suggesting
good model discrimination (Figure 6).
Discussion
Early diagnosis and properly selected surgical
interventions in acute mesenteric ischemia can re-
duce mortality.7,8 Recognition of risk factors
and comorbidities, and evaluation with appropriate
diagnostic modalities, are mandatory for the early
diagnosis of mesenteric ischemia in the ED. Patients
typically complain of severe periumbilical pain, which is
worse than that evident from physical examination.12,13
In this study, all enrolled patients had either
abdominal pain or distension, which was often
accompanied by vomiting (43.5% of patients),
gastrointestinal bleeding (20.1%), diarrhea (19.4%),
and hypotension (12.1%). Individual positive findings
on physical examination, including abdominal
tenderness, decreased or absent bowel sounds, or
rebounding pain, were apparent in over 50% of patients
in this study. However, only 32 patients (25.8%) had
a typical presentation plus massive abdominal
distension, decreased or absent bowel sounds,
rebounding and localized tenderness, and muscle
guarding indicating advanced bowel necrosis.13,14
A high index of suspicion of vascular ischemia of the
Figure 6. Receiver-operating characteristic (ROC) curve displaying
the relationship between sensitivity and specificity for the
regression-model analysis of independent variables predicting
mortality from acute mesenteric ischemia.
Table 4. Comparison of surgical procedures between survivors and non-survivors with acute mesenteric ischemia
Number (%) of patients
p
Survivors (n = 62) Non-survivors (n = 62)
Bowel resection 54 (87.1) 41 (66.1) 0.01
Laparotomy only 2 (3.2) 18 (29.0) < 0.01
Revascularization 2 (3.2) 1 (1.6) NS
Bowel resection and revascularization 4 (6.4) 1 (1.6) NS
Laparotomy and revascularization 0 (0) 1 (1.6) NS
NS = not significant.
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bowel was essential to obtain an early diagnosis. In
laboratory testing, metabolic acidosis,15–19 hyper-
amylasemia,12 and hyperphosphatemia,19,20 were pro-
posed as useful diagnostic supports for mesenteric
ischemia and infarction. However, no single, abnormal
laboratory parameter was identified in more than 90%
of patients in this study. Univariate analysis dem-
onstrated that bandemia, hyperamylasemia, hepatic
and renal impairment, and metabolic acidosis were
more frequently noted in non-survivors than survivors.
Thus, our results suggest that the degree of multiple
organ responses may be correlated with the severity of
mesenteric ischemia or infarction. Any association
between clinical presentation and abnormal laboratory
results may therefore increase the index of suspicion
for the early recognition of acute mesenteric ischemia.
Among diagnostic imaging studies, angiography is
the gold standard for diagnosing acute mesenteric
ischemia,21 and must be performed early in patients in
whom such ischemia is highly suspected. Plain
abdominal imaging has shown very low sensitivity for
detecting ischemic bowel disease.22,23 However, because
of its ready availability, improved quality, and similar
sensitivity to angiography for detecting mesenteric
ischemia,22 CT has been suggested not only for
diagnosing patients with a clinically high suspicion of
mesenteric ischemia, but also for ruling out other
causes of acute abdomen.4 Our CT scan results suggest
that intramural pneumatosis, an uncommon but more
specific finding of infarcted bowel,11,22,24 was associated
with a poor prognosis.
Besides the need to diagnose acute mesenteric
ischemia early, before infarction, knowledge of the
clinical risk factors that predict prognosis enables
emergency physicians to use more aggressive
resuscitation and treatment strategies to improve
outcomes. Aging was suggested to be an important
predictor of adverse outcomes in patients with
abdominal pain25 or mesenteric ischemia,16 as was also
demonstrated in our study in which 99 patients
(79.8%) were older than 65 years of age. In a previous
report,16 the proposed significant predictors of mortality
in mesenteric infarction were an above-mean level of
serum lactate and non-occlusive mesenteric ischemia.
We identified several significant variables from our
regression model, including old age, metabolic acidosis,
bandemia, and elevated AST and BUN levels, that
could independently predict an increased risk of death
in patients with acute mesenteric ischemia. Based on
these objective findings, considerably greater
therapeutic intervention should be attempted in the
ED in elderly patients with multiple organ dysfunction
and acute mesenteric ischemia.
Our study has some limitations. First, data were
collected from a retrospective chart review, and some
clinical presentations or imaging studies may not have
been documented in relevant medical records. Second,
we excluded patients with widespread mesenteric
infarction who did not undergo surgery because of a
critical or retractable clinical condition, and patients
with mild mesenteric ischemia who received only
medical treatment were not enrolled.
In conclusion, acute mesenteric ischemia is a
geriatric abdominal emergency that is associated with
high morbidity and mortality if not recognized and
treated early. In this study, only 1-quarter of patients
had a clinical presentation and physical examination
that was typically suggestive of acute mesenteric
ischemia. A high index of suspicion and emergency
diagnostic imaging, including CT scan or angiography,
are mandatory for early diagnosis and favorable
outcomes. For risk stratification of patients with acute
mesenteric ischemia in the ED, we identified the
following significant independent predictors of poor
prognosis: aging, bandemia, metabolic acidosis, and
elevated levels of AST and BUN. Thus, more intensive
therapeutic management and intervention is advocated
to improve outcomes in high-risk patients with acute
mesenteric ischemia.
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